Literature DB >> 19881095

Magnetic resonance imaging features of myxoid leiomyoma of the vagina: A case report.

Michele Scialpi1, Giuseppe Benagiano, Sara Frati, Irene Piscioli, Francesco Barberini, Luciano Lupattelli.   

Abstract

We report a rare case of a voluminous vaginal myxoid leiomyoma in a 27-year-old nulliparous woman. Magnetic Resonance Imaging (MRI) revealed a mass arising from the vagina, with inhomogeneous signal intensity on spin-echo T1W and T2W images. MRI accurately defined the tissue planes between the lesion and the adjacent structures and suggested its benign nature. The mass was completely resected by means of transvaginal approach and the diagnosis of myxoid leiomyoma was confirmed histologically. To the best of our knowledge, this is the first report describing the MRI features of vaginal myxoid leiomyoma.

Entities:  

Year:  2009        PMID: 19881095      PMCID: PMC2766875          DOI: 10.4103/0971-3026.54880

Source DB:  PubMed          Journal:  Indian J Radiol Imaging        ISSN: 0970-2016


Introduction

Leiomyoma is the most common benign mesenchymal tumor of the vagina in adult women.[1] Since the first report by Denys de Leyden in 1773, approximately 300 cases have been reported to date.[2] Although vaginal leiomyoma is a rare neoplasm, the clinical features have been widely described.[3] We report a rare case of a voluminous myxoid leiomyoma arising from the vagina. The emphasis is on the value of MRI in the diagnosis and management of such a lesion.

Case Report

A 27-year-old nulliparous woman was admitted to our hospital for dyspareunia, pressure symptoms on the urinary tract, vaginal pain, and fetid vaginal discharge for 20 days. On vaginal exploration there was a palpable, soft mass in the anterior wall of the vagina. Transvaginal Ultrasound (TVUS) showed a round (approximately 7 cm in diameter) heterogeneous pelvic mass, with well-defined contours [Figure 1], arising from the anterior wall of the vagina. The mass displaced the urinary bladder anteriorly and superiorly.
Figure 1

TVUS image shows a voluminous, round (approximately 7 cm in diameter), heterogeneous pelvic mass with well-defined contours arising from the anterior wall of the vagina

TVUS image shows a voluminous, round (approximately 7 cm in diameter), heterogeneous pelvic mass with well-defined contours arising from the anterior wall of the vagina In order to confirm the tumor origin and its relationships with adjacent organs, we performed MRI using a 1.5-T superconducting system (Signa Advantage; GE Medical Systems, Milwaukee, WI, USA). Sagittal, axial, and coronal T2W (TR / TE = 5000 / 100) fast spin-echo images and axial T1W (TR / TE = 460 / 14) spin-echo images, using a section of 7 mm and an intersection gap of 1 mm, were obtained. Axial T1W MRI revealed a well-circumscribed, isointense, relatively heterogeneous, rounded (7.5 cm in diameter) pelvic mass that displaced and compressed the urinary bladder anteriorly [Figure 2a]. On axial T2W images, the mass showed isointense signal with internal hyperintense irregular areas [Figure 2b]. On coronal T2W images, the mass had high internal signal intensity; it caused displacement of the uterus superiorly and distension of the vaginal fornices and vagina [Figure 3]. The acute angles between the lesion and the vaginal wall suggested a vaginal origin of the lesion. No enlarged pelvic lymph nodes were revealed. A diagnosis of a benign solid tumor arising from the vagina was made.
Figure 2 (A, B)

Axial T1W (TR / TE = 460 / 14) MRI (A) shows a wellcircumscribed, isointense, relatively heterogeneous, rounded (7.5 cm in diameter) pelvic mass (T) that displaces the urinary bladder anteriorly and compresses it. On the axial T2W (TR / TE = 5000 / 100) MRI (B), the mass (T) has an isointense signal with internal hyperintense irregular areas

Figure 3

Coronal T2W (TR / TE = 5000 / 100) MRI shows the mass (T), displacing the uterus (U) cranially, and causing distension of the fornices and enlargement of the vaginal lumen* with high signal intensity. Note the acute angles (arrows) between the tumor and vaginal wall, suggesting its vaginal origin

Axial T1W (TR / TE = 460 / 14) MRI (A) shows a wellcircumscribed, isointense, relatively heterogeneous, rounded (7.5 cm in diameter) pelvic mass (T) that displaces the urinary bladder anteriorly and compresses it. On the axial T2W (TR / TE = 5000 / 100) MRI (B), the mass (T) has an isointense signal with internal hyperintense irregular areas Coronal T2W (TR / TE = 5000 / 100) MRI shows the mass (T), displacing the uterus (U) cranially, and causing distension of the fornices and enlargement of the vaginal lumen* with high signal intensity. Note the acute angles (arrows) between the tumor and vaginal wall, suggesting its vaginal origin Surgical excision by means of a transvaginal approach was performed. Gross examination revealed a well-circumscribed soft mass, with a maximum diameter of 7.5 cm. The histology showed the typical features of a myxoid leiomyoma [Figure 4]. Abundant amorphous myxoid material was present between the smooth muscle cells. The margins were circumscribed. Cytological atypia and mitotic figures were not found. Immunohistochemical studies showed the tumor cells to be positive for muscle-specific actin. The patient was discharged on the eleventh postoperative day. Six months later she was asymptomatic and voiding normally.
Figure 4

Photomicrograph reveals the typical proliferative pattern of myxoid leiomyoma. Abundant amorphous myxoid material is present between the smooth muscle cells (H&E; 40×)

Photomicrograph reveals the typical proliferative pattern of myxoid leiomyoma. Abundant amorphous myxoid material is present between the smooth muscle cells (H&E; 40×)

Discussion

Vaginal leiomyomas may be up to 5 cm in size and may sometimes simulate malignancy (due to their size, unusual subtype, or the presence of degenerative changes). Knowledge of tumor features, especially with regard to tumor margins, relationship with adjacent structures, and size, is essential for differentiating between benign and malignant lesions preoperatively. The value of MRI in the evaluation of vaginal masses has already been established.[4] On MRI, the appearance and signal characteristics of leiomyomas are varied[5] and depend on their histological patterns (i.e., the proportion of cellular fascicles, presence of degenerative changes, and the extracellular matrix).[67] Several histologic variants of uterine leiomyoma have been defined: cellular, mitotically active, hemorrhagic, epithelioid, atypical, and lipoleiomyoma. MRI may be useful in the detection of ordinary leiomyoma. Only a few reports in the literature have described MRI findings in uterine myxoid leiomyoma. In a case reported by Cruz et al.,[8] MRI demonstrated the lesion as arising from the uterus. Contrast-enhanced Computed Tomography and MRI strongly suggested the cystic and myxoid content of the tumor. In a study of 18 uterine leiomyomas with interstitial edema and highly vascular loose connective tissue, Okizura et al.[9] observed an area of heterogeneous high signal intensity on T2W images that enhanced after gadolinium-DTPA administration. The women were premenopausal and none had received exogenous hormonal therapy before surgery. In all cases, areas of low to intermediate signal intensity on T2W images and enhancement after gadolinium-DTPA, corresponding to the final and early stages of myxoid leiomyoma, respectively, were revealed. Usually, vaginal leiomyoma shows US and MRI features similar to those observed in the uterine counterpart.[10] However, the lesion may exhibit variable signal intensities on MRI, depending on its histopathologic changes.[11] To the best of our knowledge, this is the first description of MRI findings in a myxoid leiomyoma of the vagina. In the reported cases of vaginal leiomyomas [Table 1],[10-12] the diagnosis of ordinary leiomyoma was made by MRI and confirmed histologically. Only in a case described by Shimada et al.[11] did the MRI findings suggest a diagnosis of cellular leiomyoma, whereas histological examination revealed ordinary leiomyoma. The discrepancy between the MRI features and the histologic findings was related to the abundance of vessels in the vaginal leiomyoma, which caused hyperintensity on T2W images and marked contrast enhancement on the early dynamic MRI.[11]
Table 1

MRI of leiomyoma of the vagina: review of the literature

Case/AuthorAge (years)MRI findingsHistological type
Ruggieri et al.[10]42Mass arising from the anterior wall of the vagina, displacing the vaginal canal posteriorly, with a homogeneous signal similar to that of the uterine myometrium on T1W and T2W images.*Ordinary L.
Shimada et al.[11]37Vaginal tumor, 2.2 cm in diameter, with a smooth contour and of homogeneous low signal intensity on the T1W images and homogeneous high signal intensity on T2W images. Dynamic contrast-enhanced MRI showed early homogenous marked contrast enhancement and delayed staining.Ordinary L.
Shadbolt et al.[12]30Well-circumscribed, homogeneous, solid 4 × 4.5 × 5.6-cm mass in the anterior vaginal wall, separate from the cervix, urethra, and rectum, with relatively low signal intensity on T1W and T2W images.*Ordinary L.
Shadbolt et al.[12]40Well-circumscribed, homogeneous mass of relatively low signal intensity on T1W and T2W images, arising from the right anterior vaginal wall. The mass demonstrated uniform contrast enhancement.Ordinary L.

L: leiomyoma.

Intravenous gadolinium-DTPA was not administered.

MRI of leiomyoma of the vagina: review of the literature L: leiomyoma. Intravenous gadolinium-DTPA was not administered. In our case, the T2W coronal images established the tumor origin by demonstrating acute angles between the lesion and the vagina. In spite of the large size and the inhomogeneous signal intensity of the mass on T1W and T2W images, MRI suggested the benign nature of the tumor on the basis of its regular contours and the absence of invasion of the adjacent pelvic organs. Also, MRI provided useful information for conservative surgical treatment (enucleation of the tumor).
  10 in total

1.  MR imaging of an atypical vaginal leiomyoma.

Authors:  Ken Shimada; Isamu Ohashi; Hitoshi Shibuya; Fumiko Tanabe; Takumi Akashi
Journal:  AJR Am J Roentgenol       Date:  2002-03       Impact factor: 3.959

2.  MRI of vaginal leiomyomas.

Authors:  C L Shadbolt; F V Coakley; A Qayyum; S M Donat
Journal:  J Comput Assist Tomogr       Date:  2001 May-Jun       Impact factor: 1.826

Review 3.  Vaginal masses: magnetic resonance imaging features with pathologic correlation.

Authors:  K M Elsayes; V R Narra; J R Dillman; V Velcheti; O Hameed; R Tongdee; C O Menias
Journal:  Acta Radiol       Date:  2007-10       Impact factor: 1.990

4.  The contemporary challenge of carcinoma in situ of the vulva.

Authors:  J D Woodruff; C Julian; T Puray; S Mermut; P Katayama
Journal:  Am J Obstet Gynecol       Date:  1973-03-01       Impact factor: 8.661

5.  MR imaging of uterine leiomyomas and their complications.

Authors:  D J Hamlin; H Pettersson; J Fitzsimmons; L S Morgan
Journal:  J Comput Assist Tomogr       Date:  1985 Sep-Oct       Impact factor: 1.826

Review 6.  Vulvovaginal soft tissue tumours: update and review.

Authors:  M R Nucci; C D Fletcher
Journal:  Histopathology       Date:  2000-02       Impact factor: 5.087

7.  Myxoid leiomyoma of the uterus: CT and MRI features.

Authors:  M Cruz; T Murakami; K Tsuda; H Kurachi; T Enomoto; T Kim; S Takahashi; H Nakamura
Journal:  Abdom Imaging       Date:  2001 Jan-Feb

8.  Vaginal leiomyoma. A case report with imaging findings.

Authors:  A M Ruggieri; J M Brody; R P Curhan
Journal:  J Reprod Med       Date:  1996-11       Impact factor: 0.142

9.  MR detection of degenerating uterine leiomyomas.

Authors:  H Okizuka; K Sugimura; M Takemori; C Obayashi; M Kitao; T Ishida
Journal:  J Comput Assist Tomogr       Date:  1993 Sep-Oct       Impact factor: 1.826

10.  Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms.

Authors:  H Hricak; D Tscholakoff; L Heinrichs; M R Fisher; G C Dooms; C Reinhold; R B Jaffe
Journal:  Radiology       Date:  1986-02       Impact factor: 11.105

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.